Source:http://linkedlifedata.com/resource/pubmed/id/16585597
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-4-4
|
pubmed:abstractText |
In a previous study, we demonstrated that immunization with the uveitogenic peptide interphotoreceptor retinoid-binding protein (IRBP) 1-20 induces both CD4 and CD8 uveitogenic T cells in the B6 mouse. In the current study, we determined the role of the CD8 IRBP-specific T cells in the pathogenesis of experimental autoimmune uveitis. We also determined the conditions that facilitated the activation of CD8 autoreactive T cells. Our results showed that the beta2-microglobulin(-/-) mouse had a greatly decreased susceptibility to induction of experimental autoimmune uveitis by adoptive transfer of IRBP-specific T cells from B6 mice. We also showed that unlike CD4 autoreactive T cells, activated CD8 autoreactive T cells produced only a limited number and amounts of growth factors. As a result, in the absence of exogenously supplied growth factor(s), CD8 T cell activation and expansion were aborted. However, the growth and expansion of triggered CD8 autoreactive T cells could be supported by various cytokines. In addition to factors produced by activated CD4 autoreactive T cells, factors produced by nonlymphoid cells, such as IL-7 and IL-15, and unidentified factors in the culture supernatants of astrocytes and retinal pigment epithelial cells support the CD8 autoreactive T cells as well. Finally, we showed that, although several cytokines augmented the CD8 T cell response in vitro, different cytokines appeared to act on different CD8 subsets or on different activation/differentiation phases of CD8 autoreactive T cells. As a result, cytokines, such as IL-7, supported the proliferation and survival of CD8 IRBP-specific T cells, while others had only a growth-promoting effect.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
176
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5006-14
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16585597-Adoptive Transfer,
pubmed-meshheading:16585597-Animals,
pubmed-meshheading:16585597-Autoimmune Diseases,
pubmed-meshheading:16585597-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16585597-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16585597-Cell Proliferation,
pubmed-meshheading:16585597-Cell Survival,
pubmed-meshheading:16585597-Cytokines,
pubmed-meshheading:16585597-Drug Synergism,
pubmed-meshheading:16585597-Eye Proteins,
pubmed-meshheading:16585597-Female,
pubmed-meshheading:16585597-Lymphocyte Activation,
pubmed-meshheading:16585597-Mice,
pubmed-meshheading:16585597-Mice, Inbred C57BL,
pubmed-meshheading:16585597-Mice, Knockout,
pubmed-meshheading:16585597-Retinol-Binding Proteins,
pubmed-meshheading:16585597-Uveitis
|
pubmed:year |
2006
|
pubmed:articleTitle |
In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors.
|
pubmed:affiliation |
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY 40202, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|